Related Experiment Video
Updated: Apr 21, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Protein tyrosine phosphatase-1B contributes to LPS-induced leptin resistance in male rats
Beatriz de Carvalho Borges1, Rodrigo C Rorato1, Ernane Torres Uchoa1
1Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Brazil; and.
Abstract:
Leptin resistance is induced by the feedback inhibitors tyrosine phosphatase-1B (PTP1B) and decreased Src homology 2 domain-containing tyrosine phosphatase-2 (SHP-2) signaling. To investigate the participation of PTP1B and SHP-2 in LPS-induced leptin resistance, we injected repeated (6-LPS) intraperitoneal LPS doses (100 μg/kg ip) for comparison with a single (1-LPS) treatment and evaluated the expression of SHP-2, PTP1B, p-ERK1/2, and p-STAT3 in the hypothalamus of male Wistar rats. The single LPS treatment increased the expression of p-STAT3 and PTP1B but not SHP-2. The repeated LPS treatment reduced SHP-2, increased PTP1B, and did not change p-STAT3. We observed that the PTP1B expression induced by the endotoxin was highly colocalized with leptin receptor cells in the hypothalamus of LepRb-IRES-Cre-tdTomato reporter mice. The single, but not the repeated, LPS treatment decreased the food intake and body weight. Leptin had no stimulatory effect on the hypophagia, body weight loss, or pSTAT3 expression in 6-LPS rats, indicating leptin unresponsiveness. Notably, the PTP1B inhibitor (3.0 nmol/rat in 5 μl icv) restored the LPS-induced hypophagia in 6-LPS rats and restored the ability of leptin to reduce food intake and body weight as well as to phosphorylate STAT3 in the arcuate, paraventricular, and ventromedial nuclei of the hypothalamus. The present data suggest that an increased PTP1B expression in the hypothalamus underlies the development of leptin resistance during repeated exposure to LPS. Our findings contribute to understanding the mechanisms involved in leptin resistance during low-grade inflammation as seen in obesity.
Insights
Repeated lipopolysaccharide (LPS) exposure increases tyrosine phosphatase-1B (PTP1B) in the hypothalamus, causing leptin resistance. Inhibiting PTP1B restores leptin sensitivity, suggesting PTP1B
Area of Science:
- Neuroendocrinology
- Molecular Biology
- Physiology
Background:
- Leptin resistance, a hallmark of obesity, is linked to altered signaling pathways involving tyrosine phosphatases.
- Lipopolysaccharide (LPS) exposure can induce inflammatory states that may contribute to leptin resistance.
- Tyrosine phosphatase-1B (PTP1B) and SHP-2 are key regulators of leptin receptor signaling.
Purpose of the Study:
- To investigate the role of PTP1B and SHP-2 in lipopolysaccharide (LPS)-induced leptin resistance in the rat hypothalamus.
- To determine the effects of single versus repeated LPS administration on hypothalamic signaling and leptin responsiveness.
Main Methods:
- Male Wistar rats received single or repeated intraperitoneal LPS injections.
- Expression of PTP1B, SHP-2, p-ERK1/2, and p-STAT3 was analyzed in hypothalamic tissue.
- Leptin's effects on food intake, body weight, and STAT3 phosphorylation were assessed.
- A PTP1B inhibitor was administered intracerebroventricularly to evaluate its impact on leptin resistance.
Main Results:
- Repeated LPS treatment increased hypothalamic PTP1B expression and decreased SHP-2, while p-STAT3 levels remained unchanged.
- Repeated LPS exposure induced leptin resistance, evidenced by the lack of leptin's effect on food intake, body weight, and p-STAT3.
- PTP1B inhibition restored leptin sensitivity, including reduced food intake, body weight loss, and STAT3 phosphorylation in LPS-treated rats.
Conclusions:
- Increased hypothalamic PTP1B expression is a key mechanism underlying leptin resistance induced by repeated LPS exposure.
- Targeting PTP1B may offer a therapeutic strategy for leptin resistance associated with low-grade inflammation and obesity.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
The JAK-STAT Signaling Pathway
Regulation of Food Intake
Amplifying Signals via Enzymatic Cascade
cAMP-dependent Protein Kinase Pathways

